Nidaprax

Cefixime

– Anti-infectives for systemic use –

Composition: Cefixime

Strength:

  • Capsules: 200, 400mg
  • Oral Suspension: 100 mg/5mL

Dosage Form: Capsules, Powder for oral suspension

For More Information:

Therapeutic Category: Antibacterials For Systemic Use

Indications:

  • Respiratory Tract Infections: Acute bronchitis, acute exacerbations of chronic bronchitis, mild to moderate community-acquired pneumonia (CAP), mild to moderate sinusitis.
  • Acute Otitis Media (AOM).
  • Pharyngitis and Tonsillitis.
  • Urinary Tract Infections (UTIs): Uncomplicated UTIs, pyelonephritis and other complicated UTIs caused by susceptible enterobacteriaceae, including E. coli.
  • Gonorrhea and Associated Infections: Treatment of uncomplicated urethral, endocervical, or rectal infections caused by susceptible Neisseria gonorrhoeae. Follow-up treatment of disseminated gonococcal infections after an initial parenteral regimen (ceftriaxone or, alternatively, cefotaxime, or spectinomycin).
  • Salmonella and Shigella Infections.
  • Lyme Disease.